Humira and Injection site swelling - a phase IV clinical study of FDA data

Summary:

Injection site swelling is found among people who take Humira, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Humira and have Injection site swelling. It is created by eHealthMe based on reports of 735,454 people who have side effects when taking Humira from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 15, 2023

735,454 people reported to have side effects when taking Humira.
Among them, 8,660 people (1.18%) have Injection site swelling.

What is Humira?

Humira has active ingredients of adalimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 738,352 Humira users for its effectiveness, alternative drugs and more.

What is Injection site swelling?

Injection site swelling is found to be associated with 1,866 drugs and 1,076 conditions by eHealthMe.

Number of Humira and Injection site swelling reports submitted per year:

Could Humira cause Injection site swelling?

* Approximation only. Some reports may have incomplete information.

Do you take Humira and have Injection site swelling?

Check whether Injection site swelling is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .

Related studies

How severe was Injection site swelling and when was it recovered:

Injection site swelling in Humira

Expand to all the drugs that have ingredients of adalimumab:

Injection site swelling and drugs with ingredients of adalimumab (7,874 reports)

Alternative drugs to, pros and cons of Humira:

Humira (738,352 reports)

Common Humira side effects:

Browse all side effects of Humira:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Injection site swelling treatments and more:

Injection site swelling (58,863 reports)

COVID vaccines that are related to Injection site swelling:

Common drugs associated with Injection site swelling:

All the drugs that are associated with Injection site swelling:

Injection site swelling (1,866 drugs)

Common conditions associated with Injection site swelling:

Rheumatoid arthritis: 16,901 reports
Psoriasis: 5,693 reports
Multiple sclerosis: 2,528 reports
Crohn's disease: 2,386 reports

All the conditions that are associated with Injection site swelling:

Injection site swelling (1,076 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on adalimumab (the active ingredients of Humira) and Humira (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.